How vaccine technology, choice and supply work in Switzerland - SWI swissinfo.ch
Swiss Medical Weekly - The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination
Will an mRNA vaccine alter my DNA? | Gavi, the Vaccine Alliance
Protection duration after vaccination or infection – Swiss National COVID-19 Science Task Force
Pharmaceutics | Free Full-Text | Opportunities and Challenges in the Delivery of mRNA-Based Vaccines | HTML
Frontiers | Perspectives on RNA Vaccine Candidates for COVID-19 | Molecular Biosciences
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland - ScienceDirect
Swiss Medical Weekly - Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran – a clinical case and global pharmacovigilance data
Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients | Journal for ImmunoTherapy of Cancer
Clinical and Experimental Pediatrics
Protection duration after vaccination or infection – Swiss National COVID-19 Science Task Force
Switzerland backs mRNA vaccine for booster jabs - SWI swissinfo.ch
How do mRNA vaccines work? | Covid-19 vaccination explained
mRNA Vaccines: Possible Tools to Combat SARS-CoV-2 | SpringerLink
Vaccines | Free Full-Text | An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo
BNT162b2 mRNA COVID-19 Vaccine: First Approval | SpringerLink
BNT162b2 mRNA COVID-19 Vaccine: First Approval | SpringerLink
Frontiers | Perspectives on RNA Vaccine Candidates for COVID-19 | Molecular Biosciences
How vaccine technology, choice and supply work in Switzerland - SWI swissinfo.ch
4 things about mRNA COVID vaccines researchers still want to find out | Gavi, the Vaccine Alliance
Swiss biotech innovation: global power and impact through diversity – Swiss Biotech
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates | npj Vaccines
Swiss Medical Weekly - The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination
UK firm to trial T-cell Covid vaccine that could give longer immunity | Vaccines and immunisation | The Guardian
